Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

GLSI

Greenwich LifeSciences Inc

Sep 18 • 04:00PM ET

14.17

Dollar change -0.29
Percentage change -2.01	%

Healthcare • Biotechnology • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWO VTWO IWC VTWG RSSL URTY VTHR

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.79	Insider Own	54.91%	Shs Outstand	12.85M	Perf Week	1.50%
Market Cap	186.19M	Forward P/E	-	EPS next Y	-0.82	Insider Trans	2.76%	Shs Float	5.93M	Perf Month	-0.14%
Income	-10.22M	PEG	-	EPS next Q	-0.21	Inst Own	8.43%	Short Float	7.87%	Perf Quarter	-11.27%
Sales	0.00M	P/S	-	EPS this Y	-17.39%	Inst Trans	-23.11%	Short Ratio	9.98	Perf Half Y	-16.40%
Book/sh	0.45	P/B	31.52	EPS next Y	-1.23%	ROA	-112.41%	Short Interest	0.47M	Perf Year	58.32%
Cash/sh	0.55	P/C	25.79	EPS next 5Y	-	ROE	-123.67%	52W Range	7.58 - 21.44	Perf YTD	34.70%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-36.91%	ROI	-173.92%	52W High	-33.91%	Beta	3.31
Dividend TTM	-	Quick Ratio	5.34	Sales past 5Y	0.00%	Gross Margin	-	52W Low	86.94%	ATR (14)	0.93
Dividend Ex-Date	-	Current Ratio	5.34	EPS Y/Y TTM	-14.50%	Oper. Margin	0.00%	RSI (14)	48.81	Volatility	5.38% 6.56%
Employees	7	Debt/Eq	0.00	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	38.00
Option/Short	No / Yes	LT Debt/Eq	0.00	EPS Q/Q	-59.43%	Payout	-	Rel Volume	0.36	Prev Close	14.46
Sales Surprise	-	EPS Surprise	0.00%	Sales Q/Q	-	Earnings	Aug 12	Avg Volume	46.75K	Price	14.17
SMA20	-0.23%	SMA50	-3.25%	SMA200	4.08%	Trades		Volume	17,090	Change	-2.01%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-01-21	Initiated	H.C. Wainwright	Buy	$78

Aug-01-24 06:00AM	Greenwich LifeSciences Provides Update on Expansion of Flamingo-01 into Spain (GlobeNewswire)
Jun-26-24 07:33AM	Greenwich LifeSciences Set to Join Russell 2000 Index Again (GlobeNewswire) +11.18%
Jun-17-24 09:00AM	Insider Buying: CEO and CFO Snehal Patel Acquires Shares of Greenwich LifeSciences Inc (GLSI) (GuruFocus.com) +18.16%
Jun-14-24 06:00AM	Greenwich LifeSciences Announces $2.5 Million Private Placement (GlobeNewswire)
May-20-24 09:53PM	GLSI Stock Earnings: Greenwich LifeSciences Beats EPS for Q1 2024 (InvestorPlace) -6.44%
10:53PM	Loading…
Apr-15-24 10:53PM	GLSI Stock Earnings: Greenwich LifeSciences Misses EPS for Q4 2023 (InvestorPlace) -8.88%
Apr-10-24 03:30PM	Insiders are Piling into These 10 Healthcare Stocks in 2024 (Insider Monkey)
Mar-13-24 06:00AM	Greenwich LifeSciences Extends Lock-up of Directors and Officers to June 30, 2025 (GlobeNewswire)
Mar-12-24 06:00AM	Greenwich LifeSciences Partners with GEICAM in Spain & Conducts First Site Initiation Visits in Europe (GlobeNewswire) +8.20%
Mar-07-24 09:00AM	Greenwich LifeSciences Inc (GLSI) CEO and CFO, 10% Owner Snehal Patel Acquires Additional Shares (GuruFocus.com) +19.93%
Feb-27-24 06:00AM	Greenwich LifeSciences Flamingo-01 Phase III Clinical Trial Approved to Expand into Five Largest European Countries (GlobeNewswire)
Feb-22-24 06:00AM	Greenwich LifeSciences Flamingo-01 Manufacturing & Protocol Accepted by European Regulators (GlobeNewswire)
Feb-14-24 06:00AM	Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01 (GlobeNewswire) +22.74%
Nov-21-23 06:00AM	Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2024 (GlobeNewswire)
Sep-13-23 05:02PM	Insider Buying: Snehal Patel Acquires 1,000 Shares of Greenwich LifeSciences Inc (GuruFocus.com)
01:12PM	Loading…
Jul-26-23 01:12PM	Daily Vickers Top Buyers & Sellers for 07/26/2023 (Argus Research)
Jul-18-23 06:53AM	Daily Vickers Top Buyers & Sellers for 07/18/2023 (Argus Research)
May-10-23 06:32AM	Daily Vickers Top Insider Picks for 05/10/2023 (Argus Research)
May-09-23 06:40AM	Daily Vickers Top Insider Picks for 05/09/2023 (Argus Research)
May-08-23 06:41AM	Daily Vickers Top Insider Picks for 05/08/2023 (Argus Research)
May-05-23 06:58AM	Daily Vickers Top Insider Picks for 05/05/2023 (Argus Research)
May-04-23 06:29AM	Daily Vickers Top Insider Picks for 05/04/2023 (Argus Research)
May-03-23 06:46AM	Daily Vickers Top Insider Picks for 05/03/2023 (Argus Research) +5.02%
May-02-23 06:46AM	Daily Vickers Top Insider Picks for 05/02/2023 (Argus Research)
May-01-23 06:45AM	Daily Vickers Top Insider Picks for 05/01/2023 (Argus Research) +5.88%
Apr-28-23 07:04AM	Daily Vickers Top Insider Picks for 04/28/2023 (Argus Research)
Apr-27-23 06:47AM	Daily Vickers Top Insider Picks for 04/27/2023 (Argus Research)
Apr-26-23 06:26AM	Daily Vickers Top Insider Picks for 04/26/2023 (Argus Research)
Apr-20-23 07:03AM	Daily Vickers Top Insider Picks for 04/20/2023 (Argus Research)
Apr-19-23 06:53AM	Daily Vickers Top Insider Picks for 04/19/2023 (Argus Research)
06:54AM	Loading…
Apr-17-23 06:54AM	Daily Vickers Top Insider Picks for 04/17/2023 (Argus Research)
Apr-14-23 06:37AM	Daily Vickers Top Insider Picks for 04/14/2023 (Argus Research)
Apr-13-23 06:52AM	Daily Vickers Top Insider Picks for 04/13/2023 (Argus Research)
Apr-12-23 07:07AM	Daily Vickers Top Insider Picks for 04/12/2023 (Argus Research) -5.41%
Apr-11-23 06:58AM	Daily Vickers Top Insider Picks for 04/11/2023 (Argus Research)
Apr-10-23 06:44AM	Daily Vickers Top Insider Picks for 04/10/2023 (Argus Research)
Apr-07-23 07:44AM	Daily Vickers Top Insider Picks for 04/07/2023 (Argus Research)
Apr-06-23 10:37AM	Insiders own 39% of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) shares but retail investors control 42% of the company (Simply Wall St.)
07:20AM	Daily Vickers Top Insider Picks for 04/06/2023 (Argus Research)
Apr-05-23 06:11AM	Daily Vickers Top Insider Picks for 04/05/2023 (Argus Research)
Apr-04-23 07:08AM	Daily Vickers Top Insider Picks for 04/04/2023 (Argus Research)
Apr-03-23 06:48AM	Daily Vickers Top Insider Picks for 04/03/2023 (Argus Research)
Mar-31-23 06:36AM	Daily Vickers Top Insider Picks for 03/31/2023 (Argus Research)
Mar-30-23 06:36AM	Daily Vickers Top Insider Picks for 03/30/2023 (Argus Research)
Mar-29-23 06:32AM	Daily Vickers Top Insider Picks for 03/29/2023 (Argus Research) +8.37%
Mar-28-23 06:46AM	Daily Vickers Top Insider Picks for 03/28/2023 (Argus Research) -5.86%
Mar-24-23 06:42AM	Daily Vickers Top Insider Picks for 03/24/2023 (Argus Research)
Mar-23-23 07:01AM	Daily Vickers Top Insider Picks for 03/23/2023 (Argus Research)
Mar-21-23 06:23AM	Daily Vickers Top Insider Picks for 03/21/2023 (Argus Research) +9.36%
Mar-20-23 06:35AM	Daily Vickers Top Insider Picks for 03/20/2023 (Argus Research)
Mar-17-23 06:47AM	Daily Vickers Top Insider Picks for 03/17/2023 (Argus Research)
Mar-16-23 06:51AM	Daily Vickers Top Insider Picks for 03/16/2023 (Argus Research)
Mar-15-23 06:44AM	Daily Vickers Top Insider Picks for 03/15/2023 (Argus Research)
Mar-13-23 06:32AM	Daily Vickers Top Insider Picks for 03/13/2023 (Argus Research) +8.00%
Mar-10-23 07:04AM	Daily Vickers Top Insider Picks for 03/10/2023 (Argus Research) -6.05%
Mar-09-23 06:33AM	Daily Vickers Top Insider Picks for 03/09/2023 (Argus Research) -5.43%
Mar-08-23 06:30AM	Daily Vickers Top Insider Picks for 03/08/2023 (Argus Research)
Mar-07-23 06:34AM	Daily Vickers Top Insider Picks for 03/07/2023 (Argus Research) -5.65%
Mar-06-23 07:22AM	Daily Vickers Top Insider Picks for 03/06/2023 (Argus Research)
Mar-03-23 06:38AM	Daily Vickers Top Insider Picks for 03/03/2023 (Argus Research)
Mar-02-23 06:44AM	Daily Vickers Top Insider Picks for 03/02/2023 (Argus Research) -6.81%
Mar-01-23 06:01AM	Daily Vickers Top Insider Picks for 03/01/2023 (Argus Research)
Feb-28-23 06:43AM	Daily Vickers Top Insider Picks for 02/28/2023 (Argus Research)
Feb-27-23 06:50AM	Daily Vickers Top Insider Picks for 02/27/2023 (Argus Research)
Feb-24-23 07:17AM	Daily Vickers Top Insider Picks for 02/24/2023 (Argus Research) -7.28%
Feb-23-23 07:21AM	Daily Vickers Top Insider Picks for 02/23/2023 (Argus Research)
Feb-22-23 06:56AM	Daily Vickers Top Insider Picks for 02/22/2023 (Argus Research) +5.03%
Feb-21-23 07:35AM	Daily Vickers Top Insider Picks for 02/21/2023 (Argus Research) -8.76%
Feb-17-23 06:27AM	Daily Vickers Top Insider Picks for 02/17/2023 (Argus Research)
Feb-16-23 07:28AM	Daily Vickers Top Insider Picks for 02/16/2023 (Argus Research)
Feb-15-23 07:01AM	Daily Vickers Top Insider Picks for 02/15/2023 (Argus Research)
Feb-14-23 06:23AM	Daily Vickers Top Insider Picks for 02/14/2023 (Argus Research)
Feb-13-23 07:30AM	Daily Vickers Top Insider Picks for 02/13/2023 (Argus Research) -6.58%
Feb-10-23 06:42AM	Daily Vickers Top Insider Picks for 02/10/2023 (Argus Research)
Feb-09-23 06:51AM	Daily Vickers Top Insider Picks for 02/09/2023 (Argus Research)
Feb-08-23 06:45AM	Daily Vickers Top Insider Picks for 02/08/2023 (Argus Research)
Feb-07-23 06:46AM	Daily Vickers Top Insider Picks for 02/07/2023 (Argus Research)
Feb-06-23 06:56AM	Daily Vickers Top Insider Picks for 02/06/2023 (Argus Research)
Feb-03-23 06:32AM	Daily Vickers Top Insider Picks for 02/03/2023 (Argus Research)
Feb-02-23 06:43AM	Daily Vickers Top Insider Picks for 02/02/2023 (Argus Research)
Feb-01-23 06:14AM	Daily Vickers Top Insider Picks for 02/01/2023 (Argus Research)
05:30AM	Companies Like Greenwich LifeSciences (NASDAQ:GLSI) Are In A Position To Invest In Growth (Simply Wall St.)
Jan-31-23 06:50AM	Daily Vickers Top Insider Picks for 01/31/2023 (Argus Research)
Jan-30-23 06:42AM	Daily Vickers Top Insider Picks for 01/30/2023 (Argus Research)
Jan-27-23 07:00AM	Daily Vickers Top Insider Picks for 01/27/2023 (Argus Research)
Jan-26-23 06:44AM	Daily Vickers Top Insider Picks for 01/26/2023 (Argus Research)
Jan-25-23 06:39AM	Daily Vickers Top Insider Picks for 01/25/2023 (Argus Research)
06:39AM	Daily Vickers Top Buyers & Sellers for 01/25/2023 (Argus Research)
Jan-11-23 06:53AM	Daily Vickers Top Buyers & Sellers for 01/11/2023 (Argus Research)
Jan-05-23 05:10AM	Insider Buying: The Greenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO, CFO & Director Just Bought US$61k Worth Of Shares (Simply Wall St.)
Jan-04-23 06:54AM	Daily Vickers Top Buyers & Sellers for 01/04/2023 (Argus Research)
Dec-29-22 06:51AM	Daily Vickers Top Insider Picks for 12/29/2022 (Argus Research) -9.54%
06:48AM	Greenwich LifeSciences Provides Year End Update (Business Wire)
Dec-28-22 06:58AM	Daily Vickers Top Insider Picks for 12/28/2022 (Argus Research) +9.04%
Dec-27-22 07:11AM	Daily Vickers Top Insider Picks for 12/27/2022 (Argus Research) +6.25%
Dec-23-22 06:32AM	Daily Vickers Top Insider Picks for 12/23/2022 (Argus Research)
Dec-22-22 06:34AM	Daily Vickers Top Insider Picks for 12/22/2022 (Argus Research)
Dec-21-22 09:55AM	After Golden Cross, Greenwich LifeSciences, Inc. (GLSI)'s Technical Outlook is Bright (Zacks) +8.30%
06:46AM	Daily Vickers Top Insider Picks for 12/21/2022 (Argus Research)
Dec-01-22 06:00AM	Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2023 (Business Wire)

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Thompson Jaye	VP Clinical Reg Affairs	Aug 12 '24	Buy	13.85	800	11,080	263,148	Sep 16 06:05 AM
Patel Snehal	CEO and CFO	Aug 06 '24	Buy	13.81	2,000	27,620	5,534,602	Aug 08 06:05 AM
Patel Snehal	CEO and CFO	Aug 05 '24	Buy	13.18	5,500	72,490	5,532,602	Aug 07 06:05 AM
Thompson Jaye	VP Clinical Reg Affairs	Aug 02 '24	Buy	15.15	1,000	15,150	262,348	Aug 05 06:05 AM
Patel Snehal	CEO and CFO	Jul 23 '24	Buy	15.89	1,500	23,835	5,527,102	Jul 24 06:05 AM
Thompson Jaye	VP Clinical Reg Affairs	Jul 18 '24	Buy	16.00	1,000	16,000	261,348	Jul 22 06:05 AM
Patel Snehal	CEO and CFO	Jun 13 '24	Buy	14.30	174,825	2,499,998	5,525,602	Jun 17 06:10 AM
Patel Snehal	CEO and CFO	Apr 01 '24	Buy	19.08	3,000	57,240	5,350,777	Apr 03 06:10 AM
Patel Snehal	CEO and CFO	Mar 22 '24	Buy	19.98	2,500	49,950	5,347,777	Mar 26 06:05 AM
Patel Snehal	CEO and CFO	Mar 20 '24	Buy	17.68	1,500	26,520	5,345,277	Mar 22 06:02 AM
Patel Snehal	CEO and CFO	Mar 05 '24	Buy	12.49	30,500	380,945	5,343,777	Mar 07 06:05 AM
Patel Snehal	CEO and CFO	Mar 04 '24	Buy	13.03	4,100	53,423	5,340,277	Mar 06 06:05 AM
Patel Snehal	CEO and CFO	Feb 16 '24	Buy	11.16	10,800	120,528	5,336,177	Feb 21 06:05 AM
Patel Snehal	CEO and CFO	Feb 15 '24	Buy	11.07	12,700	140,589	5,325,377	Feb 20 06:04 AM
Patel Snehal	CEO and CFO	Nov 10 '23	Buy	10.17	5,000	50,838	5,312,677	Nov 14 06:05 AM
Patel Snehal	CEO and CFO	Nov 03 '23	Buy	9.11	3,500	31,885	5,307,677	Nov 07 06:15 AM
Thompson Jaye	VP Clinical Reg Affairs	Oct 27 '23	Buy	8.57	500	4,285	260,348	Oct 31 06:16 AM
Patel Snehal	CEO and CFO	Oct 26 '23	Buy	7.97	2,500	19,925	5,304,177	Oct 30 06:15 AM
Patel Snehal	CEO and CFO	Oct 25 '23	Buy	7.91	2,500	19,775	5,301,677	Oct 27 06:15 AM
Patel Snehal	CEO and CFO	Oct 10 '23	Buy	9.07	1,000	9,070	5,299,177	Oct 12 06:05 AM
Patel Snehal	CEO and CFO	Oct 04 '23	Buy	8.63	2,000	17,260	5,298,177	Oct 05 06:05 AM
Thompson Jaye	VP Clinical Reg Affairs	Sep 26 '23	Buy	8.71	600	5,226	259,848	Sep 28 06:05 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GLSI

Greenwich LifeSciences Inc

Upgrade your FINVIZ experience